← Open Payments lookup

KATELYN GRIFFIN: Open Payments

NPI 1770012437 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$676 in 38 payments from 18 companies in 2025. Trend: 2023 $410 · 2024 $545 · 2025 $676

Food & beverage: $676
CompanyPaymentsAmount
PFIZER INC.7$139
AstraZeneca Pharmaceuticals LP5$75
Amgen Inc.5$73
Bayer Healthcare Pharmaceuticals Inc.3$57
Novartis Pharmaceuticals Corporation3$49
Boehringer Ingelheim Pharmaceuticals, Inc.2$44
Biosense Webster, Inc.1$40
BridgeBio Pharma, Inc.2$35
Edwards Lifesciences Corporation1$26
Bard Peripheral Vascular, Inc.1$22

Products named: VYNDAQEL, REPATHA, FARXIGA, Kerendia, LEQVIO, JARDIANCE, OCTARAY MAPPING CATHETER, Attruby.

Industry payments across AL — which companies pay providers there.